
Tel: 301.424.9700 · Fax: 301.296.4751 · Email: info@grs-cro.com · Other locations

GRS’ staff provides a unique set of capabilities and depth of experience in the management of clinical trials, particularly in the cardiovascular, cardio pulmonary, cardio renal, stroke, CNS, and metabolic therapeutic areas. The following table is a partial listing of our drug development experience.
| Class | Indication | No. Pts | No. Sites | Service |
|---|---|---|---|---|
| Vasodilator Combination | CHF | 1,050 | 170 | Full |
| Endothelin Receptor Antagonist | CHF | 533 | 29 | Full |
| Xanthine Oxidase Inhibitor | CHF | 400 | 40 | Full |
| Atrial Naturetic Peptide Inhibitor | CHF | 1500 | 150 | Monitoring |
| Immune Modulating Therapy | CHF | 455 | 20 | Project Mgmt, Monitoring |
| Heparin Reversal Agent | CABG | 300 | 45 | Project Mgmt, Monitoring |
| Oral Heparin | DVT | 145 | 15 | Full |
| ADH Receptor Antagonist | Hyponatremia | 200 | 55 | Project Mgmt, Monitoring |
| Adenosine Receptor Antagonist | CHF | 200 | 50 | Full |
| Beta Blocker | Hypertension | 250 | 16 | Full |
| Anti-Hypertensive HRT Combination | Hypertension/ Menopause | 236 | 43 | Monitoring |
| ACE Inhibitor | Hypertension | 500 | 44 | Project Mgmt, Monitoring |
| IIb/IIIa Glycoprotein Platelet Inhibitor | CAD | 4,815 | 150 | Full |
| Viral Protein | CAD | 72 | 12 | Full |
| Amiodarone derivative | Atrial Fibrillation | 80 | 16 | Monitoring,PM |
| Pyridoxine derivative | CABG | 435 | 10 | Montoring, Safety, PM |
| Monoclonal Antibody | CABG | 900 | 75 | Full |
GRS is experienced in the different methodologies related to the management of device and drug studies. We have done numerous studies on medical devices and are intimately aware of the study and regulatory requirements, processes, and potential hurdles involved. We bring expertise to expedite the process of moving new medical devices and in vitro diagnostics to market. The following table lists the device studies in which GRS has recently participated.
| Class | Indication | No. Pts | No. Sites | Service |
|---|---|---|---|---|
| Biliary Stent | Biliary Obstruction | 40 | 9 | Project Mgmt, Data Mgmt, Safety |
| Iliac Stent | PVD | 203 | 20 | Data Mgmt |
| OTW Device | CAD | 250 | 10 | Monitoring |
| Drug-Eluting Stent | CAD | 2000 | 40 | Monitoring |
| Stent + Device | CAD | 5000 | 150 | Full Service |
| Distal Protection Device | CAD | 150 | 15 | Monitoring |
| Debris Extraction Device | CAD | 800 | 75 | Monitoring |
| Coated Stent | CAD | 266 | 17 | Full Service |
| Coated Stent | CAD | 266 | 29 | Full Service |
| High Scaffolding Stent | CAD | 150 | 12 | Data Mgmt |
| Coated Stent + Distal Protection Device | Carotid Stenosis | 800 | 50 | Project Management and Monitoring |
| Carotid Stent | Carotid Stenosis | 50 | 15 | Data Mgmt, Safety |
| Thoracic Stent | Thoracic Aneurysm | 232 | 16 | Data Mgmt, Monitoring |
| Thoracic Stent | Thoracic Aneurysm | 390 | 35 | Monitoring |
| Abdominal Stent | Abdominal Aneurysm | 275 | 40 | Full |
| Catheter | Atrial Fibrillation | 40 | 2 | Monitoring |
| A-V Graft | Renal Failure | 50 | 8 | Full Service |
| Wound Closure Device | Post angioplasty | 540 | 12 | Full Service |